Dietary walnut oil modulates liver steatosis in the obese Zucker rat

European Journal of Nutrition

Volumn 53, Issue 2, 2014, Pages 645-660

  Fink, Anja ^a   Rüfer, Corinna E ^a   Le Grandois, Julie ^b   Roth, Alexander ^a   Aoude Werner, Dalal ^b   Marchioni, Eric ^c   Bub, Achim ^a   Barth, Stephan W ^a  

^a FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^b Aerial   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Lard; MUFA; NAFLD; PUFA; SFA

Indexed keywords

EDIBLE OIL; LARD; LIPOPROTEIN LIPASE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; OMEGA 6 FATTY ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WALNUT OIL;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; FAT CONTENT; FAT INTAKE; FATTY ACID ANALYSIS; FATTY LIVER; FEMALE; FOOD INTAKE; GENE EXPRESSION; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER WEIGHT; NONHUMAN; OBESITY; RAT; REAL TIME POLYMERASE CHAIN REACTION; WALNUT; WEIGHT GAIN;

ANIMALIA; JUGLANS; RATTUS;

ANIMALS; CARRIER PROTEINS; DIET; DIETARY FATS; DIETARY FATS, UNSATURATED; FATTY ACIDS; FATTY LIVER; FEMALE; GENE EXPRESSION; JUGLANS; LIPID METABOLISM; LIPIDS; LIPOPROTEIN LIPASE; LIVER; METABOLIC SYNDROME X; OBESITY; PLANT OILS; RATS; RATS, ZUCKER; RNA, MESSENGER; TRIGLYCERIDES;

EID: 84896727966     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-013-0573-z     Document Type: Article

References (89)

1. Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH (2009) Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond) 116:539-564
2. Chechi K, Yasui N, Ikeda K, Yamori Y, Cheema K (2010) Flax oil-mediated activation of PPAR-gamma correlates with reduction of hepatic lipid accumulation in obese spontaneously hypertensive/NDmcr-cp rats, a model of the metabolic syndrome. Br J Nutr 104:1313-1321
3. Molendi-Coste O, Legry V, Leclercq IA (2010) Dietary lipids and NAFLD: suggestions for improved nutrition. Acta Gastroenterol Belg 73:431-436
4. Day CP (2011) Non-alcoholic fatty liver disease: a massive problem. Clin Med 11:176-178
5. Della CC, Alisi A, Iorio R, Alterio A, Nobili V (2011) Expert opinion on current therapies for nonalcoholic fatty liver disease. Expert Opin Pharmacother 12:1901-1911
6. Lewis JR, Mohanty SR (2010) Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 55:560-578
7. Petta S, Muratore C, Craxi A (2009) Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dig Liver Dis 41:615-625
8. Yki-Jarvinen H (2010) Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data. Curr Opin Clin Nutr Metab Care 13:709-714
9. Krawczyk M, Bonfrate L, Portincasa P (2010) Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 24:695-708
10. Musso G, Gambino R, Cassader M (2009) Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 48:1-26
11. Postic C, Girard J (2008) The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 34:643-648
12. Vanni E, Bugianesi E, Kotronen A, De MS, Yki-Jarvinen H, Svegliati-Baroni G (2010) From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 42:320-330
13. Cohen JC, Horton JD, Hobbs HH (2011) Human fatty liver disease: old questions and new insights. Science 332:1519-1523
14. Musso G, Gambino R, De MF, Cassader M, Rizzetto M, Durazzo M, Faga E, Silli B, Pagano G (2003) Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 37:909-916
15. Parker HM, Johnson NA, Burdon CA, Cohn JS, O'Connor HT, George J (2011) Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. doi: 10.1016/j.jhep.2011.08.018
16. Toshimitsu K, Matsuura B, Ohkubo I, Niiya T, Furukawa S, Hiasa Y, Kawamura M, Ebihara K, Onji M (2007) Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition 23:46-52
17. Wall R, Ross RP, Fitzgerald GF, Stanton C (2010) Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 68:280-289
18. Araya J, Rodrigo R, Videla LA, Thielemann L, Orellana M, Pettinelli P, Poniachik J (2004) Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci (Lond) 106:635-643
19. Xu J, Cho H, O'Malley S, Park JH, Clarke SD (2002) Dietary polyunsaturated fats regulate rat liver sterol regulatory element binding proteins-1 and -2 in three distinct stages and by different mechanisms. J Nutr 132:3333-3339
20. Zivkovic AM, German JB, Sanyal AJ (2007) Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 86:285-300
21. El-Badry AM, Graf R, Clavien PA (2007) Omega 3-Omega 6: what is right for the liver? J Hepatol 47:718-725
22. Riediger ND, Othman R, Fitz E, Pierce GN, Suh M, Moghadasian MH (2008) Low n-6:n-3 fatty acid ratio, with fish- or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice. Eur J Nutr 47:153-160
23. Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, Nagai R, Ishibashi S, Osuga J, Yamada N, Shimano H (2003) Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 38:1529-1539
24. Maguire LS, O'Sullivan SM, Galvin K, O'Connor TP, O'Brien NM (2004) Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut. Int J Food Sci Nutr 55:171-178
25. Bolling BW, McKay DL, Blumberg JB (2010) The phytochemical composition and antioxidant actions of tree nuts. Asia Pac J Clin Nutr 19:117-123
26. Amaral JS, Casal S, Pereira JA, Seabra RM, Oliveira BP (2003) Determination of sterol and fatty acid compositions, oxidative stability, and nutritional value of six walnut (Juglans regia L.) cultivars grown in Portugal. J Agric Food Chem 51:7698-7702
27. Tapsell LC, Gillen LJ, Patch CS, Batterham M, Owen A, Bare M, Kennedy M (2004) Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 27:2777-2783
28. Iwamoto M, Sato M, Kono M, Hirooka Y, Sakai K, Takeshita A, Imaizumi K (2000) Walnuts lower serum cholesterol in Japanese men and women. J Nutr 130:171-176
29. Wu H, Pan A, Yu Z, Qi Q, Lu L, Zhang G, Yu D, Zong G, Zhou Y, Chen X, Tang L, Feng Y, Zhou H, Chen X, Li H, Demark-Wahnefried W, Hu FB, Lin X (2010) Lifestyle counseling and supplementation with flaxseed or walnuts influence the management of metabolic syndrome. J Nutr 140:1937-1942
30. Shimoda H, Tanaka J, Kikuchi M, Fukuda T, Ito H, Hatano T, Yoshida T (2009) Effect of polyphenol-rich extract from walnut on diet-induced hypertriglyceridemia in mice via enhancement of fatty acid oxidation in the liver. J Agric Food Chem 57:1786-1792
31. Tapsell LC, Batterham MJ, Teuss G, Tan SY, Dalton S, Quick CJ, Gillen LJ, Charlton KE (2009) Long-term effects of increased dietary polyunsaturated fat from walnuts on metabolic parameters in type II diabetes. Eur J Clin Nutr 63:1008-1015
32. Gillen LJ, Tapsell LC, Patch CS, Owen A, Batterham M (2005) Structured dietary advice incorporating walnuts achieves optimal fat and energy balance in patients with type 2 diabetes mellitus. J Am Diet Assoc 105:1087-1096
33. Ma Y, Njike VY, Millet J, Dutta S, Doughty K, Treu JA, Katz DL (2010) Effects of walnut consumption on endothelial function in type 2 diabetic subjects: a randomized controlled crossover trial. Diabetes Care 33:227-232
34. Ros E, Nunez I, Perez-Heras A, Serra M, Gilabert R, Casals E, Deulofeu R (2004) A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 109:1609-1614
35. Feldman EB (2002) The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease. J Nutr 132:1062-1101
36. Canales A, Sanchez-Muniz FJ, Bastida S, Librelotto J, Nus M, Corella D, Guillen M, Benedi J (2011) Effect of walnut-enriched meat on the relationship between VCAM, ICAM, and LTB4 levels and PON-1 activity in ApoA4 360 and PON-1 allele carriers at increased cardiovascular risk. Eur J Clin Nutr 65:703-710
37. Anderson KJ, Teuber SS, Gobeille A, Cremin P, Waterhouse AL, Steinberg FM (2001) Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J Nutr 131:2837-2842
38. Shimoda H, Tanaka J, Kikuchi M, Fukuda T, Ito H, Hatano T, Yoshida T (2008) Walnut polyphenols prevent liver damage induced by carbon tetrachloride and d-galactosamine: hepatoprotective hydrolyzable tannins in the kernel pellicles of walnut. J Agric Food Chem 56:4444-4449
39. EN ISO 12228 (1999) Animal and vegetable fats and oils - determination of individual and total sterols contents - gas chromatographic method
40. Skrivanova E, Marounek M, De SS, Raes K (2007) Influence of dietary selenium and vitamin E on quality of veal. Meat Sci 76:495-500
41. Hara A, Radin NS (1978) Lipid extraction of tissues with a low-toxicity solvent. Anal Biochem 90:420-426
42. R Core Team (2013) R: A language and environment for statistical computing. Vienna, Austria
43. Pinheiro J, Bates D, DebRoy S, Deepayan S, R Core Team (2012) nlme: linear and nonlinear mixed effects models. R package version 3.1-106
44. Fan JG, Qiao L (2009) Commonly used animal models of non-alcoholic steatohepatitis. Hepatobiliary Pancreat Dis Int 8:233-240
45. Hebbard L, George J (2011) Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 8:35-44
46. Anstee QM, Goldin RD (2006) Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87:1-16
47. Takahashi Y, Soejima Y, Fukusato T (2012) Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 18:2300-2308
48. Liu Y, Meyer C, Xu C, Weng H, Hellerbrand C, Ten DP, Dooley S (2013) Animal models of chronic liver diseases. Am J Physiol Gastrointest Liver Physiol 304:G449-G468
49. Levy JR, Clore JN, Stevens W (2004) Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats. Hepatology 39:608-616
50. Oosterveer MH, van Dijk TH, Tietge UJ, Boer T, Havinga R, Stellaard F, Groen AK, Kuipers F, Reijngoud DJ (2009) High fat feeding induces hepatic fatty acid elongation in mice. PLoS One 4:e6066-e6075
51. Yang ZH, Miyahara H, Takeo J, Hatanaka A, Katayama M (2011) Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet. Lipids Health Dis 10:189-198
52. Abete I, Goyenechea E, Zulet MA, Martinez JA (2011) Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis 21(Suppl 2):B1-B15
53. Lamaziere A, Wolf C, Barbe U, Bausero P, Visioli F (2013) Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 88:149-154
54. Nergiz-Unal R, Kuijpers MJ, de Witt SM, Heeneman S, Feijge MA, Garcia Caraballo SC, Biessen EA, Haenen GR, Cosemans JM, Heemskerk JW (2013) Atheroprotective effect of dietary walnut intake in ApoE-deficient mice: involvement of lipids and coagulation factors. Thromb Res 131:411-417
55. Mensenkamp AR, Jong MC, van Goor H, van Luyn MJ, Bloks V, Havinga R, Voshol PJ, Hofker MH, van Dijk KW, Havekes LM, Kuipers F (1999) Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver. J Biol Chem 274:35711-35718
56. Kuipers F, Jong MC, Lin Y, Eck M, Havinga R, Bloks V, Verkade HJ, Hofker MH, Moshage H, Berkel TJ, Vonk RJ, Havekes LM (1997) Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E-deficient mouse hepatocytes. J Clin Invest 100:2915-2922
57. Masterton GS, Plevris JN, Hayes PC (2010) Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther 31:679-692
58. Hussein N, Ah-Sing E, Wilkinson P, Leach C, Griffin BA, Millward DJ (2005) Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res 46:269-280
59. Burdge GC, Wootton SA (2002) Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 88:411-420
60. Harris WS (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30:785-807
61. Wong SH, Nestel PJ, Trimble RP, Storer GB, Illman RJ, Topping DL (1984) The adaptive effects of dietary fish and safflower oil on lipid and lipoprotein metabolism in perfused rat liver. Biochim Biophys Acta 792:103-109
62. Harris WS, Bulchandani D (2006) Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 17:387-393
63. Brown AM, Wiggins D, Gibbons GF (1999) Glucose phosphorylation is essential for the turnover of neutral lipid and the second stage assembly of triacylglycerol-rich ApoB-containing lipoproteins in primary hepatocyte cultures. Arterioscler Thromb Vasc Biol 19:321-329
64. Arca M, Pigna G, Favoccia C (2012) Mechanisms of diabetic dyslipidemia: relevance for atherogenesis. Curr Vasc Pharmacol 10:684-686
65. Podrini C, Borghesan M, Greco A, Pazienza V, Mazzoccoli G, Vinciguerra M (2012) Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NALFD). Curr Pharm Des 19:2737-2746
66. Botham KM, Zheng X, Napolitano M, Avella M, Cavallari C, Rivabene R, Bravo E (2003) The effects of dietary n-3 polyunsaturated fatty acids delivered in chylomicron remnants on the transcription of genes regulating synthesis and secretion of very-low-density lipoprotein by the liver: modulation by cellular oxidative state. Exp Biol Med (Maywood) 228:143-151
67. Moran-Ramos S, Avila-Nava A, Tovar AR, Pedraza-Chaverri J, Lopez-Romero P, Torres N (2012) Opuntia ficus indica (nopal) attenuates hepatic steatosis and oxidative stress in obese Zucker (fa/fa) rats. J Nutr 142:1956-1963
68. Nagao K, Inoue N, Wang YM, Shirouchi B, Yanagita T (2005) Dietary conjugated linoleic acid alleviates nonalcoholic fatty liver disease in Zucker (fa/fa) rats. J Nutr 135:9-13
69. Ahn J, Lee H, Chung CH, Ha T (2011) High fat diet induced downregulation of microRNA-467b increased lipoprotein lipase in hepatic steatosis. Biochem Biophys Res Commun 414:664-669
70. Pardina E, Baena-Fustegueras JA, Llamas R, Catalan R, Galard R, Lecube A, Fort JM, Llobera M, Allende H, Vargas V, Peinado-Onsurbe J (2009) Lipoprotein lipase expression in livers of morbidly obese patients could be responsible for liver steatosis. Obes Surg 19:608-616
71. Benhizia F, Hainault I, Serougne C, Lagrange D, Hajduch E, Guichard C, Malewiak MI, Quignard-Boulange A, Lavau M, Griglio S (1994) Effects of a fish oil-lard diet on rat plasma lipoproteins, liver FAS, and lipolytic enzymes. Am J Physiol 267:E975-E982
72. Blasiole DA, Davis RA, Attie AD (2007) The physiological and molecular regulation of lipoprotein assembly and secretion. Mol BioSyst 3:608-619
73. Raabe M, Veniant MM, Sullivan MA, Zlot CH, Bjorkegren J, Nielsen LB, Wong JS, Hamilton RL, Young SG (1999) Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest 103:1287-1298
74. Chen Z, Newberry EP, Norris JY, Xie Y, Luo J, Kennedy SM, Davidson NO (2008) ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice. J Lipid Res 49:2013-2022
75. Sampath H, Miyazaki M, Dobrzyn A, Ntambi JM (2007) Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. J Biol Chem 282:2483-2493
76. Dobrzyn A, Ntambi JM (2005) The role of stearoyl-CoA desaturase in the control of metabolism. Prostaglandins Leukot Essent Fatty Acids 73:35-41
77. Banel DK, Hu FB (2009) Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review. Am J Clin Nutr 90:56-63
78. Torabian S, Haddad E, Cordero-MacIntyre Z, Tanzman J, Fernandez ML, Sabate J (2010) Long-term walnut supplementation without dietary advice induces favorable serum lipid changes in free-living individuals. Eur J Clin Nutr 64:274-279
79. Davis PA, Vasu VT, Gohil K, Kim H, Khan IH, Cross CE, Yokoyama W (2012) A high-fat diet containing whole walnuts (Juglans regia) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model. Br J Nutr 108:1764-1772
80. Iwamoto M, Kono M, Kawamoto D, Tomoyori H, Sato M, Imaizumi K (2002) Differential effect of walnut oil and safflower oil on the serum cholesterol level and lesion area in the aortic root of apolipoprotein E-deficient mice. Biosci Biotechnol Biochem 66:141-146
81. Sampath H, Ntambi JM (2005) Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr 25:317-340
82. Wu T, Fu J, Yang Y, Zhang L, Han J (2009) The effects of phytosterols/stanols on blood lipid profiles: a systematic review with meta-analysis. Asia Pac J Clin Nutr 18:179-186
83. Kim HJ, Kim JH, Lee JW (1998) Steroid receptor coactivator-1 interacts with serum response factor and coactivates serum response element-mediated transactivations. J Biol Chem 273:28564-28567
84. Thakur ML, Sharma S, Kumar A, Bhatt SP, Luthra K, Guleria R, Pandey RM, Vikram NK (2012) Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. Atherosclerosis 223:507-511
85. Sookoian S, Castano GO, Burgueno AL, Rosselli MS, Gianotti TF, Mallardi P, Martino JS, Pirola CJ (2010) Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease. Atherosclerosis 209:585-591
86. Ito S, Yukawa T, Uetake S, Yamauchi M (2007) Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Alcohol Clin Exp Res 31:S83-S87
87. Yachi R, Igarashi O, Kiyose C (2010) Protective effects of vitamin E analogs against carbon tetrachloride-induced fatty liver in rats. J Clin Biochem Nutr 47:148-154
88. Jacobs DR, Tapsell LC (2013) Food synergy: the key to a healthy diet. Proc Nutr Soc 72:200-206
89. Musso G, Anty R, Petta S (2013) Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients? Curr Pharm Des 19:5297-5313